Literature DB >> 33747923

Morphological Subtypes of Tumor Spread Through Air Spaces in Non-Small Cell Lung Cancer: Prognostic Heterogeneity and Its Underlying Mechanism.

Huikang Xie1, Hang Su2, Erjia Zhu2, Chang Gu2, Shengnan Zhao1, Yunlang She2, Yijiu Ren2, Dong Xie2, Hui Zheng2, Chunyan Wu1, Chenyang Dai2, Chang Chen2.   

Abstract

BACKGROUND: Tumor spread through air spaces (STAS) has three morphologic subtypes: single cells, micropapillary clusters, and solid nests. However, whether their respective clinical significance is similar remains unclear.
METHODS: We retrospectively reviewed 803 patients with resected non-small cell lung cancer (NSCLC) from January to December 2009. Recurrence-free survival (RFS) and overall survival (OS) were compared among patients stratified by STAS subtypes. We also performed a prospective study of NSCLC resection specimens to evaluate the influence of a prosecting knife on the presence of STAS subtypes during specimen handling (83 cases).
RESULTS: STAS was found in 370 NSCLCs (46%), including 47 single cell STAS (13%), 187 micropapillary cluster STAS (50%), and 136 solid nest STAS (37%). STAS-negative patients had significantly better survival than patients with micropapillary cluster STAS (RFS: P < 0.001; OS: P < 0.001) and solid nest STAS (RFS: P < 0.001; OS: P < 0.001), but similar survival compared with those with single cell STAS (RFS: P = 0.995; OS: P = 0.71). Multivariate analysis revealed micropapillary cluster (RFS: P < 0.001; OS: P < 0.001) and solid nest STAS (RFS: P = 0.001; OS: P = 0.003) to be an independent prognostic indicator, but not for single cell STAS (RFS: P = 0.989; OS: P = 0.68). Similar results were obtained in subgroup analysis of patients with adenocarcinoma. The prospective study of NSCLC specimens suggested that 18 cases were considered as STAS false-positive, and most were singe cell pattern (13/18, 72%).
CONCLUSIONS: Single cell STAS was the common morphologic type of artifacts produced by a prosecting knife. A precise protocol of surgical specimen handling is required to minimize artifacts as much as possible.
Copyright © 2021 Xie, Su, Zhu, Gu, Zhao, She, Ren, Xie, Zheng, Wu, Dai and Chen.

Entities:  

Keywords:  artifact; non-small cell lung cancer; prognosis; spread through a knife surface; spread through air spaces

Year:  2021        PMID: 33747923      PMCID: PMC7970243          DOI: 10.3389/fonc.2021.608353

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  25 in total

1.  Spread through air spaces is a predictive factor of recurrence and a prognostic factor in stage I lung adenocarcinoma.

Authors:  Satoshi Shiono; Naoki Yanagawa
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-06-26

2.  Ex Vivo Artifacts and Histopathologic Pitfalls in the Lung.

Authors:  Erik Thunnissen; Hans J L G Blaauwgeers; Erienne M V de Cuba; Ching Yong Yick; Douglas B Flieder
Journal:  Arch Pathol Lab Med       Date:  2016-03       Impact factor: 5.534

3.  A Prospective Study of Loose Tissue Fragments in Non-Small Cell Lung Cancer Resection Specimens: An Alternative View to "Spread Through Air Spaces".

Authors:  Hans Blaauwgeers; Douglas Flieder; Arne Warth; Alexander Harms; Kim Monkhorst; Birgit Witte; Erik Thunnissen
Journal:  Am J Surg Pathol       Date:  2017-09       Impact factor: 6.394

4.  Semiquantitative Assessment of Tumor Spread through Air Spaces (STAS) in Early-Stage Lung Adenocarcinomas.

Authors:  Hironori Uruga; Takeshi Fujii; Sakashi Fujimori; Tadasu Kohno; Kazuma Kishi
Journal:  J Thorac Oncol       Date:  2017-03-28       Impact factor: 15.609

Review 5.  The Eighth Edition Lung Cancer Stage Classification.

Authors:  Frank C Detterbeck; Daniel J Boffa; Anthony W Kim; Lynn T Tanoue
Journal:  Chest       Date:  2016-10-22       Impact factor: 9.410

6.  Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosis.

Authors:  Maristela L Onozato; Alexandra E Kovach; Beow Y Yeap; Vicente Morales-Oyarvide; Veronica E Klepeis; Swathi Tammireddy; Rebecca S Heist; Eugene J Mark; Dora Dias-Santagata; A John Iafrate; Yukako Yagi; Mari Mino-Kenudson
Journal:  Am J Surg Pathol       Date:  2013-02       Impact factor: 6.394

7.  Significance of Spread Through Air Spaces in Resected Pathological Stage I Lung Adenocarcinoma.

Authors:  Gouji Toyokawa; Yuichi Yamada; Tetsuzo Tagawa; Yuka Kozuma; Taichi Matsubara; Naoki Haratake; Shinkichi Takamori; Takaki Akamine; Yoshinao Oda; Yoshihiko Maehara
Journal:  Ann Thorac Surg       Date:  2018-02-14       Impact factor: 4.330

8.  Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score-Matched Analysis.

Authors:  Takashi Eguchi; Koji Kameda; Shaohua Lu; Matthew J Bott; Kay See Tan; Joseph Montecalvo; Jason C Chang; Natasha Rekhtman; David R Jones; William D Travis; Prasad S Adusumilli
Journal:  J Thorac Oncol       Date:  2018-09-19       Impact factor: 15.609

Review 9.  Updates on spread through air spaces (STAS) in lung cancer.

Authors:  Angela R Shih; Mari Mino-Kenudson
Journal:  Histopathology       Date:  2020-01-14       Impact factor: 5.087

10.  Significance of spread through air spaces in early-stage lung adenocarcinomas undergoing limited resection.

Authors:  Gouji Toyokawa; Yuichi Yamada; Tetsuzo Tagawa; Yoshinao Oda
Journal:  Thorac Cancer       Date:  2018-08-06       Impact factor: 3.500

View more
  3 in total

1.  Clinicopathological Impact of the Spread through Air Space in Non-Small Cell Lung Cancer: A Meta-Analysis.

Authors:  Jung-Soo Pyo; Nae Yu Kim
Journal:  Diagnostics (Basel)       Date:  2022-04-28

Review 2.  [Research Progress on Spread Through Air Spaces of Lung Cancer].

Authors:  Lei Fan; Ping He
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-12-23

3.  To explore the prognostic value of spread through air spaces and develop a nomogram combined with spread through air spaces in lung squamous cell carcinoma.

Authors:  Hongyan Yu; Chengbin Lin; Xiaohan Chen; Zheng Wang; Weiyu Shen
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.